Feasibility and validity of mobile cognitive testing in patients with substance use disorders and healthy controls
Am J Addict. 2018-09-27; 27(7): 553-556
DOI: 10.1111/ajad.12804
Lire sur PubMed
1. Am J Addict. 2018 Oct;27(7):553-556. doi: 10.1111/ajad.12804.
Feasibility and validity of mobile cognitive testing in patients with substance
use disorders and healthy controls.
Bouvard A(1), Dupuy M(2), Schweitzer P(2), Revranche M(2), Fatseas M(3), Serre
F(3), Misdrahi D(2)(4), Auriacombe M(3), Swendsen J(2)(5).
Author information:
(1)University Paris-Sud, Orsay, France.
(2)University of Bordeaux, CNRS-UMR 5287-Institut de Neurosciences Cognitives et
Intégratives d’Aquitaine (INCIA), Bordeaux, France.
(3)Addiction Psychiatry Team, SANPsy CNRS USR 3413, Pôle Addictologie, CH Charles
Perrens and CHU de Bordeaux, Bordeaux, France.
(4)Pole de Psychiatrie 347, C.H. Charles Perrens, Bordeaux cedex, France.
(5)EPHE, PSL Research University, Paris, France.
BACKGROUND AND OBJECTIVES: Mobile testing of executive deficits in
substance-related addictions is highly novel but requires validation.
METHODS: Sixty-one individuals (34 patients, 27 healthy controls) completed
Ecological Momentary Assessments with mobile executive tests.
RESULTS: Compliance with the tests was high (78% to 91%) in both the patient and
control groups. No fatigue effects were detected, practice effects were observed
for controls only, and convergent validity was found relative to
neuropsychological assessments. Conclusions The use of mobile cognitive testing
is feasible and valid in this population. Scientific Significance Mobile
cognitive tests provide new opportunities for both research and clinical
intervention. (Am J Addict 2018;27:553-556).
© 2018 American Academy of Addiction Psychiatry.
DOI: 10.1111/ajad.12804
PMID: 30260085